These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 2574687

  • 1. Systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine reduces the release of [3H]dopamine from rat striatal slices.
    Kurstjens NP, Cantrill RC.
    Eur J Pharmacol; 1989 Oct 04; 169(1):147-52. PubMed ID: 2574687
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. 1-methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway.
    Bradbury AJ, Costall B, Domeney AM, Jenner P, Kelly ME, Marsden CD, Naylor RJ.
    Nature; 1989 Oct 04; 319(6048):56-7. PubMed ID: 3484542
    [Abstract] [Full Text] [Related]

  • 5. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
    Sirinathsinghji DJ, Heavens RP, McBride CS.
    Brain Res; 1988 Mar 08; 443(1-2):101-16. PubMed ID: 3258784
    [Abstract] [Full Text] [Related]

  • 6. In vitro release of tritiated monoamines from rat CNS tissue by the neurotoxic compound 1-methyl-phenyl-tetrahydropyridine.
    Schmidt CJ, Matsuda LA, Gibb JW.
    Eur J Pharmacol; 1984 Aug 17; 103(3-4):255-60. PubMed ID: 6333347
    [Abstract] [Full Text] [Related]

  • 7. Behavioural effects and supersensitivity in the rat following intranigral MPTP and MPP+ administration.
    Lange KW.
    Eur J Pharmacol; 1990 Jan 03; 175(1):57-61. PubMed ID: 2323346
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.
    Javitch JA, D'Amato RJ, Strittmatter SM, Snyder SH.
    Proc Natl Acad Sci U S A; 1985 Apr 03; 82(7):2173-7. PubMed ID: 3872460
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal dopamine receptor system.
    Lau YS, Fung YK.
    Brain Res; 1986 Mar 26; 369(1-2):311-5. PubMed ID: 3486026
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [The effect of prolyl-leucyl-glycine (MIF-1) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on dopamine levels of the striatum].
    Sheng JG.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Aug 26; 22(4):213-5, 253. PubMed ID: 2575971
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Depletion of striatal dopamine by the N-oxide of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Lau YS, Fung YK, Trobough KL, Cashman JR, Wilson JA.
    Neurotoxicology; 1991 Aug 26; 12(2):189-99. PubMed ID: 1956580
    [Abstract] [Full Text] [Related]

  • 15. Reduction of dopamine uptake and cocaine binding in mouse striatum by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Sershen H, Reith ME, Hashim A, Lajtha A.
    Eur J Pharmacol; 1984 Jun 15; 102(1):175-8. PubMed ID: 6332738
    [Abstract] [Full Text] [Related]

  • 16. Potentiation by the tetraphenylboron anion of the effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its pyridinium metabolite.
    Heikkila RE, Hwang J, Ofori S, Geller HM, Nicklas WJ.
    J Neurochem; 1990 Mar 15; 54(3):743-50. PubMed ID: 2303810
    [Abstract] [Full Text] [Related]

  • 17. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on striatal dopamine receptors in C57BL/6 mice.
    Bhargava HN, Perlow MJ.
    Toxicol Lett; 1988 Mar 15; 40(3):219-24. PubMed ID: 3258448
    [Abstract] [Full Text] [Related]

  • 18. The effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on presynaptic dopamine uptake sites in the mouse striatum.
    Donnan GA, Kaczmarczyk SJ, Rowe PJ, Figdor R, Mendelsohn FA.
    J Neurol Sci; 1986 Jun 15; 74(1):111-9. PubMed ID: 3487620
    [Abstract] [Full Text] [Related]

  • 19. Neurochemical and functional consequences following 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) and methamphetamine.
    Jarvis MF, Wagner GC.
    Life Sci; 1985 Jan 21; 36(3):249-54. PubMed ID: 3871245
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.